- United States
- /
- Software
- /
- NasdaqGS:CHKP
Should Check Point’s (CHKP) Microsoft Partnership on AI Security Prompt a Closer Look by Investors?
- Check Point Software Technologies announced in November 2025 that it is collaborating with Microsoft to deliver enterprise-grade AI security for Microsoft Copilot Studio, integrating continuous protection, compliance, and governance tools directly into AI development workflows.
- This partnership extends Check Point's AI security stack, aiming to safeguard organizations' use of generative AI by addressing new risks such as prompt injection and data leakage during agent runtime.
- We'll explore how Check Point's integration of AI security with Microsoft Copilot Studio supports its focus on innovation-led growth in enterprise security.
This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.
Check Point Software Technologies Investment Narrative Recap
To be a shareholder in Check Point Software Technologies, you typically need to believe in the long-term demand for enterprise security innovation, especially as companies modernize IT environments and adopt AI. The recent collaboration with Microsoft enhances Check Point's AI security stack, yet its immediate impact on Check Point's key near-term catalyst, the adoption of its Infinity platform, does not appear to be material; however, it does strengthen Check Point's positioning in enterprise AI security. Meanwhile, the most significant risk continues to be potential revenue delays due to macroeconomic uncertainties that could slow customer deal flow in the coming quarters.
Among recent announcements, Check Point’s October 2025 collaboration with Wiz to deliver a fully integrated network and cloud-native application protection platform closely aligns with its Microsoft partnership. Both initiatives showcase Check Point’s ongoing efforts to address emerging security challenges for enterprises moving workloads to the cloud and adopting AI, supporting its ongoing focus on innovation-led customer growth across hybrid environments.
On the other hand, investors should be aware that delayed deals from macroeconomic headwinds could...
Read the full narrative on Check Point Software Technologies (it's free!)
Check Point Software Technologies' outlook anticipates $3.1 billion in revenue and $989.0 million in earnings by 2028. This scenario assumes a 5.9% annual revenue growth rate and a $130.9 million increase in earnings from the current level of $858.1 million.
Uncover how Check Point Software Technologies' forecasts yield a $228.40 fair value, a 22% upside to its current price.
Exploring Other Perspectives
Five members of the Simply Wall St Community estimate Check Point’s fair value in a broad range from US$108.10 to US$228.40 per share. These differing views come as the company continues to face potential revenue delays from shifting deal timelines, making it valuable to consider multiple perspectives on future performance.
Explore 5 other fair value estimates on Check Point Software Technologies - why the stock might be worth 42% less than the current price!
Build Your Own Check Point Software Technologies Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Check Point Software Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Check Point Software Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Check Point Software Technologies' overall financial health at a glance.
Ready For A Different Approach?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:CHKP
Check Point Software Technologies
Develops, markets, and supports a range of products and services for IT security worldwide.
Flawless balance sheet with solid track record.
Similar Companies
Market Insights
Weekly Picks

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

EU#4 - Turning Heritage into the World’s Strongest Luxury Empire

The "Easy Money" Is Gone: Why Alphabet Is Now a "Show Me" Story
Recently Updated Narratives

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Novo Nordisk - A Fundamental and Historical Valuation

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Popular Narratives

The "Sleeping Giant" Stumbles, Then Wakes Up
Undervalued Key Player in Magnets/Rare Earth


